DHL builds pharma momentum by landing BMS deal

DHL will buy Bristol-Myers Squibb distribution centers in Mount Vernon, IN, as part of a deal in which it assumes U.S. distribution for the drug giant. The carrier will provide operations and finished goods distribution services, including cold chain storage. The deal continues DHL's momentum in the pharma industry; in February, it took over direct-to-pharmacy deliveries for Pfizer Australia and earlier this month integrated its ordering and billing systems with cold-chain specialist CryoPort's order-entry and tracking web portal. Item

Suggested Articles

A biotech that worked with a nutritional products maker on the API for its clinical-stage radiation drug, is buying all of the manufacturing know-how.

Merck KGaA is selling a manufacturing site and its Allergopharma allergy drug business as it focuses on newer meds.

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S.